Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 333

1.

Glucagon-like peptide-1 and diabetes 2012.

Monami M, Di Pasquale G, Rowzee A, Rotella CM, Mannucci E.

Exp Diabetes Res. 2012;2012:768760. doi: 10.1155/2012/768760. Epub 2012 Dec 31. No abstract available.

2.

Impact of GLP-1 receptor agonists on major gastrointestinal disorders for type 2 diabetes mellitus: a mixed treatment comparison meta-analysis.

Sun F, Yu K, Yang Z, Wu S, Zhang Y, Shi L, Ji L, Zhan S.

Exp Diabetes Res. 2012;2012:230624. doi: 10.1155/2012/230624. Epub 2012 Dec 26. Review.

3.

Autonomic nervous system, inflammation, and diabetes: mechanisms and possible interventions.

Irigoyen MC, Casarini DE, Morris M, Montano N.

Exp Diabetes Res. 2012;2012:894157. doi: 10.1155/2012/894157. Epub 2012 Dec 31. No abstract available.

4.

5HT(2A) and 5HT(2B) receptors contribute to serotonin-induced vascular dysfunction in diabetes.

Nelson PM, Harrod JS, Lamping KG.

Exp Diabetes Res. 2012;2012:398406. doi: 10.1155/2012/398406. Epub 2012 Dec 30.

5.

Animal models of diabetes mellitus for islet transplantation.

Sakata N, Yoshimatsu G, Tsuchiya H, Egawa S, Unno M.

Exp Diabetes Res. 2012;2012:256707. doi: 10.1155/2012/256707. Epub 2012 Dec 30. Review.

6.

Noncoding RNAs.

Hardikar AA, Walker MD, Lynn F.

Exp Diabetes Res. 2012;2012:629249. doi: 10.1155/2012/629249. Epub 2012 Dec 29. No abstract available.

7.

Inflammation and oxidative stress in obesity, metabolic syndrome, and diabetes.

Galassetti P.

Exp Diabetes Res. 2012;2012:943706. doi: 10.1155/2012/943706. Epub 2012 Dec 24. No abstract available.

8.

Prevalence and risk factors of prolonged QTc interval among Chinese patients with type 2 diabetes.

Li X, Ren H, Xu ZR, Liu YJ, Yang XP, Liu JQ.

Exp Diabetes Res. 2012;2012:234084. doi: 10.1155/2012/234084. Epub 2012 Dec 25.

9.

Associations of common variants at APLN and hypertension in Chinese subjects with and without diabetes.

Zhang R, Lu J, Hu C, Wang C, Yu W, Jiang F, Tang S, Bao Y, Xiang K, Jia W.

Exp Diabetes Res. 2012;2012:917496. doi: 10.1155/2012/917496. Epub 2012 Dec 17.

10.

Single diabetic QTL derived from OLETF rat is a sufficient agent for severe diabetic phenotype in combination with leptin-signaling deficiency.

Kose H, Yamada T, Matsumoto K.

Exp Diabetes Res. 2012;2012:858121. doi: 10.1155/2012/858121. Epub 2012 Dec 5.

11.

Beneficial effects of aminoguanidine on skin flap survival in diabetic rats.

Ozturk A, Fırat C, Parlakpınar H, Bay-Karabulut A, Kirimlioglu H, Gurlek A.

Exp Diabetes Res. 2012;2012:721256. doi: 10.1155/2012/721256. Epub 2012 Dec 13.

12.

Correlation between blood activin levels and clinical parameters of type 2 diabetes.

Wu H, Wu M, Chen Y, Allan CA, Phillips DJ, Hedger MP.

Exp Diabetes Res. 2012;2012:410579. doi: 10.1155/2012/410579. Epub 2012 Dec 16.

13.

Investigating endothelial activation and oxidative stress in relation to glycaemic control in a multiethnic population.

Brady EM, Webb DR, Morris DH, Khunti K, Talbot DS, Sattar N, Davies MJ.

Exp Diabetes Res. 2012;2012:386041. doi: 10.1155/2012/386041. Epub 2012 Dec 6.

14.
15.

BDKRB2 +9/-9 polymorphism is associated with higher risk for diabetes mellitus in the Brazilian general population.

de Oliveira Alvim R, Santos PC, Nascimento RM, Coelho GL, Mill JG, Krieger JE, Pereira AC.

Exp Diabetes Res. 2012;2012:480251. doi: 10.1155/2012/480251. Epub 2012 Nov 29.

16.

Increased inflammation in atherosclerotic lesions of diabetic Akita-LDLr⁻/⁻ mice compared to nondiabetic LDLr⁻/⁻ mice.

Engelbertsen D, To F, Dunér P, Kotova O, Söderberg I, Alm R, Gomez MF, Nilsson J, Bengtsson E.

Exp Diabetes Res. 2012;2012:176162. doi: 10.1155/2012/176162. Epub 2012 Nov 28.

17.

Impact of maternal diabetes on epigenetic modifications leading to diseases in the offspring.

Vrachnis N, Antonakopoulos N, Iliodromiti Z, Dafopoulos K, Siristatidis C, Pappa KI, Deligeoroglou E, Vitoratos N.

Exp Diabetes Res. 2012;2012:538474. doi: 10.1155/2012/538474. Epub 2012 Nov 22. Review.

18.

Adipocytokine levels in genetically high risk for type 2 diabetes in the Indian population: a cross-sectional study.

Bose KS, Gupta SK, Vyas P.

Exp Diabetes Res. 2012;2012:386524. doi: 10.1155/2012/386524. Epub 2012 Nov 14.

19.

Dipeptidyl peptidase 4 inhibition may facilitate healing of chronic foot ulcers in patients with type 2 diabetes.

Marfella R, Sasso FC, Rizzo MR, Paolisso P, Barbieri M, Padovano V, Carbonara O, Gualdiero P, Petronella P, Ferraraccio F, Petrella A, Canonico R, Campitiello F, Della Corte A, Paolisso G, Canonico S.

Exp Diabetes Res. 2012;2012:892706. doi: 10.1155/2012/892706. Epub 2012 Nov 1.

20.

KU-32, a novel drug for diabetic neuropathy, is safe for human islets and improves in vitro insulin secretion and viability.

Farmer K, Williams SJ, Novikova L, Ramachandran K, Rawal S, Blagg BS, Dobrowsky R, Stehno-Bittel L.

Exp Diabetes Res. 2012;2012:671673. doi: 10.1155/2012/671673. Epub 2012 Nov 1.

Supplemental Content

Loading ...
Support Center